treatment T

• Recruiting NCT NCT04620187

  Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

  Not yet reported Dana-Farber Cancer Institute 37 participants Est. completion 2029-02-01 13 sites Stand-alone
  Other conditions: Salivary Gland Cancer, HER2 Gene Mutation
  View official trial listing →
• Terminated NCT NCT00138359

  Mass Treatment T Solium Community Study

  Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 4200 participants Est. completion 2005-01 1 site
  Other conditions: Intestinal Parasitism
  View official trial listing →
• Completed NCT NCT00777322

  T-Cat Laser & Cross-linking for Keratoconus

  Not yet reported Moorfields Eye Hospital NHS Foundation Trust 15 participants Est. completion 2010-10 1 site
  Other conditions: Keratoconus, Pellucid Marginal Degeneration
  View official trial listing →
• Completed NCT NCT01398111

  Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers

  Not yet reported Chiesi Farmaceutici S.p.A. 44 participants Est. completion 2011-08 1 site Stand-alone
  Other conditions: COPD
  View official trial listing →
• Completed NCT NCT01406158

  A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet Formulation

  Not yet reported Astellas Pharma Inc 24 participants Est. completion 2011-07 1 site Stand-alone
  Other conditions: Pharmacokinetics of Solifenacin Succinate, Healthy Volunteers
  View official trial listing →
• Completed NCT NCT01452542

  A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects

  Not yet reported Genzyme, a Sanofi Company 22 participants Est. completion 2011-11 1 site Stand-alone
  Other conditions: Healthy Volunteer
  View official trial listing →
• Completed NCT NCT01475058

  CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

  Not yet reported, Not yet reported Fred Hutchinson Cancer Center 1 participants Est. completion 2014-07 1 site
  Other conditions: Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Chronic Lymphocytic Leukemia
  View official trial listing →
• Terminated NCT NCT01630564

  Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies

  Not yet reported M.D. Anderson Cancer Center 2 participants Est. completion 2018-05-30 1 site
  Other conditions: Hematopoietic and Lymphoid Cell Neoplasm
  View official trial listing →
• Completed NCT NCT02027935

  CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma

  Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2024-04-12 1 site
  Other conditions: Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7
  View official trial listing →
• Completed NCT NCT02241863

  The Effect of a Theory Based Educational Intervention on Medication Adherence to and Removes of Related Barriers in Patients With Bipolar Disorder

  Not yet reported Qazvin University Of Medical Sciences 270 participants 10 sites Stand-alone
  Other conditions: Patients With Bipolar Disorders
  View official trial listing →
• Status unknown NCT NCT02281266

  Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection

  Not yet reported Jia Fan 360 participants Est. completion 2018-10 1 site
  Other conditions: Curable Hepatitis B Virus-Related Hepatocellular Carcinoma
  View official trial listing →
• Completed NCT NCT02572752

  Relative Bioavailability of 2 Oral Formulations of Nintedanib

  Not yet reported Boehringer Ingelheim 70 participants Est. completion 2015-11 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03151499

  Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

  Not yet reported Boehringer Ingelheim 15 participants Est. completion 2017-07-11 1 site
  Other conditions: Healthy
  View official trial listing →
• Terminated NCT NCT03300544

  Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

  Not yet reported National Cancer Institute (NCI) 3 participants Est. completion 2022-03-22 1 site
  Other conditions: Locally Advanced Rectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Rectal Adenocarcinoma, Stage III Rectal Cancer AJCC v7, Stage IIIA Rectal Cancer AJCC v7, Stage IIIB Rectal Cancer AJCC v7, Stage IIIC Rectal Cancer AJCC v7, Stage IV Rectal Cancer AJCC v7, Stage IVA Rectal Cancer AJCC v7, Stage IVB Rectal Cancer AJCC v7
  View official trial listing →
• Completed NCT NCT03318900

  T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer

  Not yet reported, Not yet reported M.D. Anderson Cancer Center 5 participants Est. completion 2023-12-20 1 site
  Other conditions: COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive, Recurrent Ovarian Carcinoma
  View official trial listing →
• Completed NCT NCT03505151

  This Study in Healthy Men and Women Tests How the Body Takes up BI 409306

  Not yet reported Boehringer Ingelheim 9 participants Est. completion 2018-05-19 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03629054

  This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

  Not yet reported Boehringer Ingelheim 30 participants Est. completion 2018-11-05 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03629067

  Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

  Not yet reported Boryung Pharmaceutical Co., Ltd 60 participants Est. completion 2018-12-27 1 site Stand-alone
  Other conditions: Pharmacokinetics
  View official trial listing →
• Completed NCT NCT03783000

  A Study in Healthy Men to Measure the Amount of BI 425809 in the Blood When Taken as a Tablet

  Not yet reported Boehringer Ingelheim 6 participants Est. completion 2019-03-06 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03804671

  A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet

  Not yet reported Boehringer Ingelheim 6 participants Est. completion 2019-03-26 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03817619

  Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet

  Not yet reported Radboud University Medical Center 11 participants Est. completion 2019-07-30 1 site Stand-alone
  Other conditions: Hepatitis C, Deglutition Disorders
  View official trial listing →
• Completed NCT NCT03818607

  A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH

  Not yet reported Amgen 42 participants Est. completion 2022-07-12 24 sites
  Other conditions: Paroxysmal Nocturnal Hemoglobinuria
  View official trial listing →
• Completed NCT NCT03837964

  A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men

  Not yet reported Boehringer Ingelheim 12 participants Est. completion 2019-04-24 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03864666

  Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

  Not yet reported Genovate Biotechnology Co., Ltd., 28 participants Est. completion 2019-05-03 1 site
  Alcohol use disorder
  View official trial listing →
• Completed NCT NCT03867136

  Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

  Not yet reported Huashan Hospital 354 participants Est. completion 2024-08-10 13 sites
  Other conditions: Multidrug Resistant Tuberculosis
  View official trial listing →
• Completed NCT NCT03871595

  A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2019-04-24 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT03904576

  A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms

  Not yet reported Boehringer Ingelheim 20 participants Est. completion 2019-08-29 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04011241

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1323495 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2019-09-06 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04028479

  The Registry of Oncology Outcomes Associated With Testing and Treatment

  Taproot Health 167 participants Est. completion 2024-10-31 2 sites
  Obstructive sleep apnea Other conditions: Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer, Appendix Cancer, Brain Tumor, Glioblastoma, Astrocytoma, Bile Duct Cancer, Cholangiocarcinoma, Bladder Cancer, Bone Cancer, Synovial Sarcoma, Sarcoma, Kaposi, Sarcoma,Soft Tissue, Sarcoma, CNS Cancer, Brain Stem Neoplasms, Breast Cancer, Cervical Cancer, Colorectal Cancer, Rectal Cancer, Colon Cancer, Esophageal Cancer, Esophagus Cancer, Cancer of Colon, Pancreatic Cancer, Cancer of Pancreas, Testis Cancer, Testicular Cancer, Ureter Cancer, Renal Cell Carcinoma, Kidney Cancer, Gestational Trophoblastic Tumor, Head and Neck Neoplasms, Parotid Tumor, Larynx Cancer, Tongue Cancer, Pharynx Cancer, Salivary Gland Cancer, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Multiple Myeloma, Non Hodgkin Lymphoma, Carcinoid Tumor, Lung Cancer, Neuroendocrine Tumors, Mesothelioma, Thyroid Cancer, Parathyroid Neoplasms, Adrenal Cancer, Small Bowel Cancer, Stomach Cancer, Liver Cancer, Hepatic Cancer, Melanoma, Skin Cancer, Unknown Primary Tumors, Uterine Cancer, Fallopian Tube Cancer, Ovarian Cancer, Prostate Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Waldenstrom Macroglobulinemia, Cancer, Advanced, Thymus Cancer, Nasopharyngeal Carcinoma, Multiple Endocrine Neoplasia, Pheochromocytoma, Small Cell Carcinoma, Pulmonary Carcinoma
  View official trial listing →
• Status unknown NCT NCT04306354

  Use of Intranasal Oxytocin During Detoxification of Crack Cocaine

  Not yet reported, Not yet reported Pontificia Universidade Católica do Rio Grande do Sul 96 participants Est. completion 2020-05-31 1 site
  Other conditions: Cocaine Withdrawal, Cocaine Smoking, Cocaine-Related Disorders
  View official trial listing →
• Completed NCT NCT04563845

  Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin

  Not yet reported ViiV Healthcare 50 participants Est. completion 2021-10-30 1 site Stand-alone
  Other conditions: HIV Infections
  View official trial listing →
• Status unknown NCT NCT04592822

  A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition

  Not yet reported Hong Kong WD Pharmaceutical Co., Limited 20 participants Est. completion 2021-12-06 Stand-alone
  Other conditions: Anticoagulant
  View official trial listing →
• Completed NCT NCT04619251

  A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood

  Not yet reported Boehringer Ingelheim 74 participants Est. completion 2021-08-03 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04674826

  A Trial to Compare the Pharmacokinetics of Tralokinumab in Healthy Subjects

  Not yet reported LEO Pharma 101 participants Est. completion 2021-12-29 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04714073

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2021-04-30 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04716894

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2021-04-01 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04717908

  Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

  Not yet reported Huashan Hospital 89 participants Est. completion 2024-06-22 15 sites
  Other conditions: Multidrug Resistant Tuberculosis
  View official trial listing →
• Completed NCT NCT04725682

  Bioequivalence Study of Tacrolimus in Healthy Volunteers

  Not yet reported Food and Drug Administration (FDA) 67 participants Est. completion 2021-06-17 1 site
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT04739774

  Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast)

  Not yet reported Chiesi Farmaceutici S.p.A. 24 participants Est. completion 2021-04-26 1 site Stand-alone
  Other conditions: Chronic Obstructive Pulmonary Disease
  View official trial listing →
• Completed NCT NCT04819906

  Effect of Estetrol Monohydrate (E4) on QTc Interval

  Not yet reported Estetra 32 participants Est. completion 2021-07-14 1 site Stand-alone
  Other conditions: Prolonged QTc Interval
  View official trial listing →
• Completed NCT NCT04844424

  A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants

  Not yet reported Janssen Research & Development, LLC 115 participants Est. completion 2022-07-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04893733

  Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI

  Not yet reported Caja Nacional de Salud 260 participants Est. completion 2022-04-30 1 site Stand-alone
  Other conditions: Acute Kidney Injury
  View official trial listing →
• Status unknown NCT NCT04910126

  Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma

  Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 84 participants Est. completion 2023-11-12 1 site
  Other conditions: Soft Tissue Sarcoma, Neoplasms, Connective and Soft Tissue, Sarcoma Metastatic, Sarcoma,Soft Tissue
  View official trial listing →
• Completed NCT NCT04958252

  A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated

  Not yet reported Boehringer Ingelheim 56 participants Est. completion 2023-10-30 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04966325

  Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects

  Not yet reported LG Chem 37 participants Est. completion 2021-12-07 1 site Stand-alone
  Other conditions: Hyperuricemia, Gout, Qt Interval, Variation in
  View official trial listing →
• Completed NCT NCT05076409

  A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood

  Not yet reported Boehringer Ingelheim 15 participants Est. completion 2022-01-10 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05129696

  Integrating Early Stimulation and Play at Scale: "MAHAY Mikolo"

  Not yet reported University of California, Berkeley 8150 participants Est. completion 2025-03-31 1 site
  Other conditions: Early Childhood Development
  View official trial listing →
• Terminated NCT NCT05191862

  Bioequivalence Study of PMR Compared to Cilostazol IR Tablets in Healthy Volunteers

  Not yet reported Genovate Biotechnology Co., Ltd., 19 participants Est. completion 2022-05-07 1 site
  Alcohol use disorder
  View official trial listing →
• Completed NCT NCT05203289

  A Study in Healthy People to Test How 2 Different Formulations of BI 695501 Are Taken up by the Body When Given as an Injection

  Not yet reported Boehringer Ingelheim 200 participants Est. completion 2022-08-29 2 sites
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05466734

  BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

  Not yet reported Genovate Biotechnology Co., Ltd., 25 participants Est. completion 2022-09-20 1 site
  Alcohol use disorder
  View official trial listing →
• Completed NCT NCT05515588

  A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2022-11-17 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05707403

  A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body

  Not yet reported Boehringer Ingelheim 8 participants Est. completion 2023-03-28 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05723874

  A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2023-05-26 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05833139

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of Zongertinib (BI 1810631) in the Blood

  Not yet reported Boehringer Ingelheim 16 participants Est. completion 2023-06-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05896384

  A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood

  Not yet reported Boehringer Ingelheim 32 participants Est. completion 2025-03-26 1 site
  Other conditions: Healthy
  View official trial listing →
• Terminated NCT NCT05934942

  A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

  Not yet reported Boehringer Ingelheim 29 participants Est. completion 2024-02-08 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT05965583

  A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1815368 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2023-10-24 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06041438

  A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2023-11-10 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06167265

  BE Study of Once Daily PMR Compared to Twice Daily Cilostazol Tablets in Healthy Volunteers

  Not yet reported Genovate Biotechnology Co., Ltd., 40 participants Est. completion 2024-01-18 1 site
  Alcohol use disorder
  View official trial listing →
• Completed NCT NCT06200467

  A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

  Not yet reported Boehringer Ingelheim 110 participants Est. completion 2025-10-22 1 site
  Other conditions: Overweight, Obesity
  View official trial listing →
• Completed NCT NCT06360081

  A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers

  Not yet reported Boehringer Ingelheim 56 participants Est. completion 2024-07-15 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06367153

  A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood

  Not yet reported Boehringer Ingelheim 18 participants Est. completion 2024-08-20 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06393127

  A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body

  Not yet reported Boehringer Ingelheim 64 participants Est. completion 2024-09-10 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06395610

  Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers

  Not yet reported Chiesi Farmaceutici S.p.A. 24 participants Est. completion 2024-06-18 1 site Stand-alone
  Other conditions: Chronic Obstructive Pulmonary Disease
  View official trial listing →
• Completed NCT NCT06504862

  A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood

  Not yet reported Boehringer Ingelheim 32 participants Est. completion 2024-12-18 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT06591845

  Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects

  Not yet reported Shanghai Ark Biopharmaceutical Co., Ltd. 34 participants Est. completion 2024-12-23 1 site Stand-alone
  Other conditions: Healthy Volunteers
  View official trial listing →
• Completed NCT NCT06649942

  A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults

  Not yet reported Kaken Pharmaceutical 40 participants Est. completion 2025-03-24 1 site Stand-alone
  Other conditions: Healthy Volunteers - Male and Female
  View official trial listing →
• Completed NCT NCT06861829

  A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood

  Not yet reported Boehringer Ingelheim 12 participants Est. completion 2025-04-23 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT07368569

  A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the Body

  Not yet reported Boehringer Ingelheim 14 participants Est. completion 2026-03-17 1 site
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT07412015

  Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

  Not yet reported Chipscreen Biosciences, Ltd. 24 participants Est. completion 2026-05-28 1 site Stand-alone
  Type 2 diabetes
  View official trial listing →
• Not yet recruiting NCT NCT07837648

  A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in Two Different Ways

  Not yet reported Boehringer Ingelheim 30 participants Est. completion 2026-12-15
  Other conditions: Healthy
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT07412015

Also known as: treatment T, treatment T (dose 1), treatment T (dose 2)